Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma In Situ: 15-Year Recurrence Rates and Outcome After a Recurrence, From the EORTC 10853 Randomized Phase III Trial

Adjuvant Tamoxifen Reduces Subsequent Breast Cancer in Women With Estrogen Receptor–Positive Ductal Carcinoma in Situ: A Study Based on NSABP Protocol B-24

(2012) D. Craig Allred et al.   JOURNAL OF CLINICAL ONCOLOGY

Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS

(2011) I. L. Wapnir et al.   JNCI-Journal of the National Cancer Institute

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials

(2011)   LANCET

Quality Indicators for Breast Cancer: Revisiting Historical Evidence in the Context of Technology Changes

(2011) Philip Poortmans et al.   SEMINARS IN RADIATION ONCOLOGY

Ductal Carcinoma In Situ of the Breast: A Systematic Review of Incidence, Treatment, and Outcomes

(2010) B. A. Virnig et al.   JNCI-Journal of the National Cancer Institute

Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial

(2010) Jack Cuzick et al.   LANCET ONCOLOGY

Second solid cancers after radiotherapy for breast cancer in SEER cancer registries

(2009) A Berrington de Gonzalez et al.   BRITISH JOURNAL OF CANCER

Analysis of Survival by Tumor Response and Other Comparisons of Time-to-Event by Outcome Variables

(2008) James R. Anderson et al.   JOURNAL OF CLINICAL ONCOLOGY

Absolute Risk Reductions for Local Recurrence After Postoperative Radiotherapy After Sector Resection for Ductal Carcinoma In Situ of the Breast

(2008) Lars Holmberg et al.   JOURNAL OF CLINICAL ONCOLOGY